Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
LGF-B
|
Daniel E. Sanchez
Director |
SELL
Open market or private sale
|
Direct | 3,214 Reduced 71.07% |
$50,235
$15.63 p/Share
|
Apr 09
2019 |
ZYXI
|
Thomas Sandgaard
PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect | 78,917 Reduced 0.52% |
$376,434
$4.77 p/Share
|
Apr 08
2019 |
CARG
|
Parafestas Anastasios
Director |
SELL
Open market or private sale
|
Indirect | 6,600 Reduced 0.09% |
$264,792
$40.12 p/Share
|
Apr 08
2019 |
ITRI
|
Scopia Capital Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 335 Reduced 0.01% |
$16,080
$48.0 p/Share
|
Apr 08
2019 |
Y
|
William K Lavin
Director |
SELL
Open market or private sale
|
Direct | 518 Reduced 19.36% |
$318,860
$615.56 p/Share
|
Apr 08
2019 |
AMR
|
Charles Andrew Eidson
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 2,292 Reduced 5.44% |
$138,735
$60.53 p/Share
|
Apr 08
2019 |
AMR
|
James Scott Kreutzer
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 630 Reduced 3.75% |
$38,159
$60.57 p/Share
|
Apr 08
2019 |
AADI
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 27,525 Reduced 0.54% |
$28,075
$1.02 p/Share
|
Apr 08
2019 |
LIN
|
Stephen F Angel
Director |
SELL
Open market or private sale
|
Direct | 54,994 Reduced 24.33% |
$10,144,194
$184.46 p/Share
|
Apr 08
2019 |
GHDX
|
Baker Bros. Advisors LP
Director |
SELL
Open market or private sale
|
Indirect | 22,648 Reduced 0.17% |
$1,537,799
$67.9 p/Share
|
Apr 08
2019 |
AADI
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 24,661 Reduced 0.48% |
$25,154
$1.02 p/Share
|
Apr 05
2019 |
GHDX
|
Baker Bros. Advisors LP
Director |
SELL
Open market or private sale
|
Indirect | 77,648 Reduced 0.29% |
$5,332,088
$68.67 p/Share
|
Apr 05
2019 |
SMAR
|
Insight Holdings Group, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 2,751 Reduced 1.26% |
$107,344
$39.02 p/Share
|
Apr 05
2019 |
LLY
|
Aarti S. Shah
SVP & CIDO |
SELL
Open market or private sale
|
Direct | 1,800 Reduced 8.9% |
$226,530
$125.85 p/Share
|
Apr 05
2019 |
LIN
|
Matthew J White
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 7,773 Reduced 25.11% |
$1,438,160
$185.02 p/Share
|
Apr 05
2019 |
PKDC
|
Highbridge Capital Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 0.06% |
$17,790
$17.79 p/Share
|
Apr 05
2019 |
PKDC
|
Highbridge Capital Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 87,781 Reduced 2.87% |
$1,518,611
$17.3 p/Share
|
Apr 05
2019 |
SNX
|
Kevin M Murai
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 25.82% |
$517,600
$103.52 p/Share
|
Apr 05
2019 |
FDX
|
Frederick W Smith
Executive Chairman |
SELL
Open market or private sale
|
Direct | 155,650 Reduced 1.04% |
$29,576,614
$190.02 p/Share
|
Apr 05
2019 |
ZYXI
|
Thomas Sandgaard
PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect | 4,277 Reduced 0.03% |
$20,316
$4.75 p/Share
|
Apr 05
2019 |
AAPL
|
Luca Maestri
Senior Vice President, CFO |
SELL
Open market or private sale
|
Direct | 51,138 Reduced 65.07% |
$10,054,242
$196.61 p/Share
|
Apr 05
2019 |
MDLY
|
Jacobs Asset Management, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 4,223 Reduced 0.67% |
$14,316
$3.39 p/Share
|
Apr 05
2019 |
CARG
|
Parafestas Anastasios
Director |
SELL
Open market or private sale
|
Indirect | 60,000 Reduced 0.8% |
$2,482,200
$41.37 p/Share
|
Apr 05
2019 |
ITRI
|
Scopia Capital Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 4,340 Reduced 0.1% |
$208,450
$48.03 p/Share
|
Apr 05
2019 |
ZYXI
|
Thomas Sandgaard
PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect | 3,392 Reduced 0.02% |
$16,112
$4.75 p/Share
|
Apr 04
2019 |
BALY
|
Solus Alternative Asset Management LP |
SELL
Open market or private sale
|
Indirect | 500 Reduced 0.01% |
$15,525
$31.05 p/Share
|
Apr 04
2019 |
BALY
|
Solus Alternative Asset Management LP |
SELL
Open market or private sale
|
Indirect | 115,000 Reduced 2.73% |
$3,565,000
$31.0 p/Share
|
Apr 04
2019 |
AADI
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 47,900 Reduced 0.92% |
$48,379
$1.01 p/Share
|
Apr 04
2019 |
PKDC
|
Highbridge Capital Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 20,526 Reduced 0.66% |
$328,005
$15.98 p/Share
|
Apr 04
2019 |
CARG
|
Parafestas Anastasios
Director |
SELL
Open market or private sale
|
Indirect | 60,000 Reduced 0.4% |
$2,477,400
$41.29 p/Share
|
Apr 04
2019 |
GHDX
|
Baker Bros. Advisors LP
Director |
SELL
Open market or private sale
|
Indirect | 81,053 Reduced 0.61% |
$5,401,372
$66.64 p/Share
|
Apr 04
2019 |
UNP
|
Robert M Knight Jr
EVP & CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 10.56% |
$1,700,100
$170.01 p/Share
|
Apr 04
2019 |
WTM
|
Morgan W Davis
Director |
SELL
Open market or private sale
|
Indirect | 910 Reduced 13.98% |
$840,522
$923.65 p/Share
|
Apr 04
2019 |
AMR
|
Kevin S Crutchfield
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 7,957 Reduced 4.26% |
$475,829
$59.8 p/Share
|
Apr 04
2019 |
SMAR
|
Insight Holdings Group, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 6,600 Reduced 1.47% |
$253,836
$38.46 p/Share
|
Apr 04
2019 |
BALY
|
Solus Alternative Asset Management LP |
SELL
Open market or private sale
|
Indirect | 400 Reduced 0.01% |
$12,400
$31.0 p/Share
|
Apr 03
2019 |
AMGN
|
Ronald D Sugar
Director |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 13.25% |
$386,360
$193.18 p/Share
|
Apr 03
2019 |
ZYXI
|
Thomas Sandgaard
PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect | 13,414 Reduced 0.09% |
$63,716
$4.75 p/Share
|
Apr 03
2019 |
ADI
|
Martin Cotter
SVP, Ind, Consr, Multi-Markets |
SELL
Open market or private sale
|
Direct | 680 Reduced 79.72% |
$74,542
$109.62 p/Share
|
Apr 03
2019 |
SNX
|
Dwight Steffensen
Director |
SELL
Open market or private sale
|
Direct | 1,295 Reduced 100.0% |
$130,484
$100.76 p/Share
|
Apr 03
2019 |
SNX
|
Simon Leung
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 4.28% |
$100,120
$100.12 p/Share
|
Apr 03
2019 |
NVDA
|
Debora Shoquist
EVP, Operations |
SELL
Open market or private sale
|
Direct | 5,823 Reduced 3.28% |
$1,077,255
$185.0 p/Share
|
Apr 03
2019 |
MA
|
Michael Miebach
President & CEO |
SELL
Open market or private sale
|
Direct | 2,711 Reduced 13.23% |
$651,399
$240.28 p/Share
|
Apr 03
2019 |
AMR
|
Kevin S Crutchfield
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 8,259 Reduced 4.24% |
$497,605
$60.25 p/Share
|
Apr 03
2019 |
SQ
|
Jack Dorsey
Block Head and Chairperson |
SELL
Open market or private sale
|
Indirect | 103,035 Reduced 88.79% |
$7,933,695
$77.0 p/Share
|
Apr 03
2019 |
PLXS
|
Dean A Foate
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 4.09% |
$630,000
$63.0 p/Share
|
Apr 03
2019 |
AADI
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 58,033 Reduced 1.11% |
$55,712
$0.96 p/Share
|
Apr 03
2019 |
INTC
|
Steven Ralph Rodgers
EVP General Counsel |
SELL
Open market or private sale
|
Direct | 25,170 Reduced 34.33% |
$1,384,350
$55.0 p/Share
|
Apr 03
2019 |
PKDC
|
Highbridge Capital Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 27,295 Reduced 1.71% |
$439,450
$16.1 p/Share
|
Apr 03
2019 |
PKDC
|
Highbridge Capital Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 430 Reduced 0.01% |
$7,435
$17.29 p/Share
|
Apr 03
2019 |